Reynoso Jamie L.
CEO, Medicare Advantage
Reynoso Jamie L. has filed 33 SEC Form 4 filings (39 transaction rows) across 1 company, with disclosures dating back to 2025. 25 of those filings fall inside the rolling window. Most recent filing: Oct 20, 2026.
On the most recent filing, Reynoso Jamie L. is listed as CEO, Medicare Advantage at CLOVER HEALTH INVESTMENTS, CORP. /DE. Inside the rolling window, Reynoso Jamie L. reported no open-market purchases and 18 open-market sales totaling $558K in CLOV. The largest disclosed transaction in the window is a sale of 30,385 CLOV shares on Nov 4, 2025, worth $109K.
Companies traded
Other insiders at CLOV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$558K
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| CLOV | CEO, Medicare Advantage | Sale | 4,066 | $18K | Oct 20 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 18,273 | $86K | Oct 19 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 2,006 | $9K | Oct 7 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 8,750 | $39K | Oct 5 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 1,921 | $9K | Sep 18 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 9,273 | $44K | Sep 15 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 4,839 | $22K | Jul 17 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 13,119 | $61K | Jul 16 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 2,384 | $11K | Jul 9 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 6,229 | $33K | Jul 6 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 2,360 | $11K | Jun 18 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 6,350 | $29K | Jun 16 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 7,289 | $36K | Jun 11 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 5,833 | $11K | Mar 18 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 4,597 | $12K | Jan 20 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 2,102 | $5K | Jan 7 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 4,913 | $13K | Dec 18 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 30,385 | $109K | Nov 5 | SEC ↗ |
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Reynoso Jamie L. made?
Reynoso Jamie L. has filed 33 SEC Form 4 filings (39 transaction rows) across 1 company since 2025.
Which companies does Reynoso Jamie L. trade?
Reynoso Jamie L. has filed SEC Form 4 disclosures for 1 company, including CLOV.
When was Reynoso Jamie L.'s most recent SEC Form 4 filing?
Reynoso Jamie L.'s most recent SEC Form 4 filing on Tracefour is dated Oct 20, 2026.
What is Reynoso Jamie L.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Reynoso Jamie L. is listed as CEO, Medicare Advantage.
What is Reynoso Jamie L.'s total buy and sell value in the current window?
Inside the rolling retention window, Reynoso Jamie L. bought $0 and sold $558K based on SEC Form 4 filings.
What was Reynoso Jamie L.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 30,385 CLOV shares on 2025-11-04, worth $109K, per SEC Form 4 filings.